P/E at 67.20 vs Industry's 66.76: What the Data Shows for Max Healthcare Institute Ltd

Valuation Picture: Slight Premium Amid Sector Parity

The current P/E of 67.20 for Max Healthcare Institute Ltd is just above the hospital sector’s average of 66.76, indicating that the stock is trading at a modest premium relative to its peers. This premium suggests that investors are pricing in either superior earnings growth prospects or a higher quality of earnings compared to the broader sector. However, the narrow margin between the stock’s P/E and the industry average tempers any strong valuation divergence. Max Healthcare Institute Ltd’s market capitalisation stands at ₹1,01,963.98 crores, placing it firmly in the mid-cap category within the hospital sector.

Performance Across Timeframes: Divergent Momentum Signals

Examining the stock’s returns over multiple periods reveals a complex performance profile. Over the past year, Max Healthcare Institute Ltd has declined by 10.72%, slightly underperforming the Sensex’s 10.29% fall. However, the year-to-date (YTD) return of 0.26% contrasts sharply with the Sensex’s more pronounced decline of 12.61%, indicating some resilience in the current calendar year. The one-month return of 3.35% also outpaces the Sensex’s negative 3.57%, suggesting recent short-term strength.

Conversely, the three-month return of -3.98% is marginally worse than the Sensex’s -3.79%, hinting at a recent loss of momentum. This divergence between short-term gains and medium-term weakness raises the question of whether the recent rally is sustainable or a temporary reprieve — is this a genuine recovery or a relief rally that will fade at the 50 DMA? The stock’s one-week and one-day performances, at +1.00% and +1.34% respectively, further underscore the recent positive momentum, outperforming the Sensex’s negative 0.41% and positive 0.22% returns in the same periods.

Moving Average Configuration: Mixed Technical Signals

The technical picture for Max Healthcare Institute Ltd is characterised by a mixed moving average (MA) configuration. The stock currently trades above its 5-day and 20-day moving averages, signalling short-term bullishness and recent buying interest. However, it remains below its 50-day, 100-day, and 200-day moving averages, which typically represent medium to long-term trend indicators. This setup suggests that while the stock has experienced a short-term bounce, it is still within a broader downtrend or consolidation phase.

Such a configuration often points to a recovery attempt within a larger corrective pattern — is this a one-quarter anomaly or the start of a structural revenue problem? The stock’s three-day consecutive gain, with a cumulative rise of 0.81%, supports the notion of a short-term rebound, but the longer-term moving averages act as resistance levels that need to be overcome for a sustained uptrend.

Sector Performance Context: Mixed Hospital Industry Results

The hospital sector, within which Max Healthcare Institute Ltd operates, has exhibited a mixed performance profile recently. While some stocks in the sector have recorded positive returns, others have remained flat or declined, reflecting varied operational and market dynamics. The sector’s average P/E of 66.76 indicates a valuation level that is broadly consistent with Max Healthcare Institute Ltd’s own valuation, suggesting that the stock is neither significantly overvalued nor undervalued relative to its peers.

This sector backdrop provides a useful frame of reference for analysing the stock’s performance and valuation — should investors in Max Healthcare Institute Ltd hold, buy more, or reconsider?

Rating Reassessment: Previously Rated Hold

On 28 Aug 2026, Max Healthcare Institute Ltd’s rating was updated from its previous Hold status, reflecting a reassessment of its fundamentals and market position. The stock’s Mojo Score currently stands at 40.0, with a Sell grade assigned. This change signals a shift in the evaluation of the stock’s risk-reward profile, although the precise nature of the rating adjustment is not disclosed. The data-driven approach behind this reassessment considers valuation, performance, and technical indicators comprehensively.

Collective Data Insights: A Stock at a Crossroads

The data for Max Healthcare Institute Ltd paints a picture of a stock balancing between short-term recovery and longer-term challenges. Its valuation premium over the hospital sector is modest, reflecting a market view that is cautiously optimistic but not exuberant. Performance metrics reveal a stock that has struggled over the past year but has shown signs of resilience in recent months, outperforming the Sensex on a YTD and one-month basis.

The mixed moving average configuration further emphasises this tension, with short-term averages signalling strength while longer-term averages suggest resistance and a broader downtrend. The rating reassessment from Hold to a Sell grade underscores the evolving risk profile, inviting investors to consider whether the recent gains represent a sustainable turnaround or a temporary bounce — what is the current rating?

Overall, the interplay of valuation, performance, and technical indicators suggests that Max Healthcare Institute Ltd remains at a critical juncture, with data pointing to both opportunities and cautionary signals.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today